|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2001. View Article : Google Scholar
|
|
2
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llovet JM, Ricci S, Mazzaferro V, et al:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Je Y, Schutz FA and Choueiri TK: Risk of
bleeding with vascular endothelial growth factor receptor
tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic
review and meta-analysis of clinical trials. Lancet Oncol.
10:967–974. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jang M, Cai L, Udeani GO, et al: Cancer
chemopreventive activity of resveratrol, a natural product derived
from grapes. Science. 275:218–220. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bishayee A, Politis T and Darvesh AS:
Resveratrol in the chemoprevention and treatment of hepatocellular
carcinoma. Cancer Treat Rev. 36:43–53. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL and
Pan CE: Effect of resveratrol and in combination with 5-FU on
murine liver cancer. World J Gastroenterol. 10:3048–3052.
2004.PubMed/NCBI
|
|
9
|
George J, Singh M, Srivastava AK, et al:
Resveratrol and black tea polyphenol combination synergistically
suppress mouse skin tumors growth by inhibition of activated MAPKs
and p53. PLoS One. 6:e233952011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iwuchukwu OF, Tallarida RJ and Nagar S:
Resveratrol in combination with other dietary polyphenols
concomitantly enhances antiproliferation and UGT1A1 induction in
Caco-2 cells. Life Sci. 88:1047–1054. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Zhang J, Wang Y, et al: Matrine, a
novel autophagy inhibitor, blocks trafficking and the proteolytic
activation of lysosomal proteases. Carcinogenesis. 34:128–138.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang S, Zhang Y, Zhuang Y, et al: Matrine
induces apoptosis in human acute myeloid leukemia cells via the
mitochondrial pathway and Akt inactivation. PLoS One. 7:e468532012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou H, Xu M, Gao Y, et al: Matrine
induces caspase-independent program cell death in hepatocellular
carcinoma through bid-mediated nuclear translocation of apoptosis
inducing factor. Mol Cancer. 13:592014. View Article : Google Scholar
|
|
14
|
Zhang L, Wang T, Wen X, et al: Effect of
matrine on HeLa cell adhesion and migration. Eur J Pharmacol.
563:69–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang T, Zhu Y, Luo C, et al: Matrine
inhibits the activity of translation factor eIF4E through
dephosphorylation of 4E-BP1 in gastric MKN45 cells. Planta Med.
73:1176–1181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun M, Cao H, Sun L, et al: Antitumor
activities of kushen: literature review. Evid Based Complement
Alternat Med. 2012:3732192012.PubMed/NCBI
|
|
17
|
Yu Q, Chen B, Zhang X, Qian W, Ye B and
Zhou Y: Arsenic trioxide-enhanced, matrine-induced apoptosis in
multiple myeloma cell lines. Planta Med. 79:775–781. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chou TC and Talalay P: Quantitative
analysis of dose-effect relationships: the combined effects of
multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao N, Shang B, Zhang X, et al: Potent
antitumor actions of the new antibiotic boningmycin through
induction of apoptosis and cellular senescence. Anticancer Drug.
22:166–175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Joe AK, Liu H, Suzui M, Vural ME, Xiao D
and Weinstein IB: Resveratrol induces growth inhibition, S-phase
arrest, apoptosis, and changes in biomarker expression in several
human cancer cell lines. Clin Cancer Res. 8:893–903.
2002.PubMed/NCBI
|
|
21
|
Garvin S, Ollinger K and Dabrosin C:
Resveratrol induces apoptosis and inhibits angiogenesis in human
breast cancer xenografts in vivo. Cancer Lett. 231:113–122. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: the in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stervbo U, Vang O and Bonnesen C: Time-
and concentration-dependent effects of resveratrol in HL-60 and
HepG2 cells. Cell Prolif. 39:479–493. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wong RS: Apoptosis in cancer: from
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiang H, Zhang L, Kuo J, et al:
Resveratrol-induced apoptotic death in human U251 glioma cells. Mol
Cancer Ther. 4:554–561. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kai L, Samuel SK and Levenson AS:
Resveratrol enhances p53 acetylation and apoptosis in prostate
cancer by inhibiting MTA1/NuRD complex. Int J Cancer.
126:1538–1548. 2010.PubMed/NCBI
|
|
27
|
Scarlatti F, Sala G, Somenzi G, Signorelli
P, Sacchi N and Ghidoni R: Resveratrol induces growth inhibition
and apoptosis in metastatic breast cancer cells via de novo
ceramide signaling. FASEB J. 17:2339–2341. 2003.PubMed/NCBI
|
|
28
|
Cepero E, King AM, Coffey LM, Perez RG and
Boise LH: Caspase-9 and effector caspases have sequential and
distinct effects on mitochondria. Oncogene. 24:6354–6366.
2005.PubMed/NCBI
|
|
29
|
Kumar S: Caspase function in programmed
cell death. Cell Death Differ. 14:32–43. 2007. View Article : Google Scholar
|
|
30
|
Bagci EZ, Vodovotz Y, Billiar TR,
Ermentrout GB and Bahar I: Bistability in apoptosis: roles of bax,
bcl-2, and mitochondrial permeability transition pores. Biophys J.
90:1546–1559. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Du Q, Hu B, An HM, et al: Synergistic
anticancer effects of curcumin and resveratrol in Hepa1–6
hepatocellular carcinoma cells. Oncol Rep. 29:1851–1858.
2013.PubMed/NCBI
|
|
32
|
Pan X, Zhang X, Sun H, Zhang J, Yan M and
Zhang H: Autophagy inhibition promotes 5-fluorouraci-induced
apoptosis by stimulating ROS formation in human non-small cell lung
cancer A549 cells. PLoS One. 8:e566792013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Singh RP, Dhanalakshmi S, Agarwal C and
Agarwal R: Silibinin strongly inhibits growth and survival of human
endothelial cells via cell cycle arrest and downregulation of
survivin, Akt and NF-κB: implications for angioprevention and
antiangiogenic therapy. Oncogene. 24:1188–1202. 2005.PubMed/NCBI
|
|
34
|
Wang T, Wei J, Qian X, Ding Y, Yu L and
Liu B: Gambogic acid, a potent inhibitor of survivin, reverses
docetaxel resistance in gastric cancer cells. Cancer Lett.
262:214–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Circu ML and Aw TY: Reactive oxygen
species, cellular redox systems, and apoptosis. Free Radic Biol
Med. 48:749–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kirkland RA and Franklin JL: Bax, reactive
oxygen, and cytochrome c release in neuronal apoptosis.
Antioxid Redox Signal. 5:589–596. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miki H, Uehara N, Kimura A, et al:
Resveratrol induces apoptosis via ROS-triggered autophagy in human
colon cancer cells. Int J Oncol. 40:1020–1028. 2012.PubMed/NCBI
|
|
38
|
Tan C, Qian X, Jia R, Wu M and Liang Z:
Matrine induction of reactive oxygen species activates p38 leading
to caspase-dependent cell apoptosis in non-small cell lung cancer
cells. Oncol Rep. 30:2529–2535. 2013.PubMed/NCBI
|
|
39
|
Hussain AR, Uddin S, Bu R, et al:
Resveratrol suppresses constitutive activation of AKT via
generation of ROS and induces apoptosis in diffuse large B cell
lymphoma cell lines. PLoS One. 6:e247032011. View Article : Google Scholar : PubMed/NCBI
|
